Homes
Public Notices
News
Local news
Editor’s Pick
Pittsburgh
Local Government
Roads, Travel and Traffic
20 Years of Gas Drilling
Regional
U.S. and World
Business
Sports
HS Sports
College Sports
Penguins
Pirates
Steelers
Athlete of the Week
Wild Things
Pony Baseball
Outdoors
Columns
Opinion
Columns
Editorials
Letters to the Editor
Op Eds
Living
Neighbors
School News
Entertainment
Home and Garden
Food
Police Beat
Obituaries
Classifieds
Legal Notices
Sponsored Content
e-Edition
close
Washington County
Greene County
Mon Valley
News
Local news
Police Beat
Pittsburgh
Local Government
Roads, Travel and Traffic
Helping The Helpers
20 Years of Gas Drilling
Regional
U.S. and World
Business News
Sports
High School Sports
College Sports
Penguins
Pirates
Steelers
Wild Things
Pro Sports
Outdoors
Sports Column
Obituaries
Opinion
Columns
Editorials
Letters to the Editor
Op-Ed
Living
Neighbors
Health and Wellness
Entertainment
Home and Garden
Classifieds
Contact Us
Advertise With Us
Customer Service
Contact Information
Submission Forms
Statement of Values
Misc
Special Sections
Events
Sponsored Content
Newsletter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Zentalis Pharmaceuticals, Inc. - common stock
(NQ:
ZNTL
)
3.455
-0.035 (-1.00%)
Streaming Delayed Price
Updated: 11:11 AM EST, Jan 13, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Zentalis Pharmaceuticals, Inc. - common stock
< Previous
1
2
3
4
Next >
Zentalis Secures $150M In Equity Funding
↗
June 29, 2021
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) priced an underwritten public offering of 3.1 million shares at $48.50 per share, for gross proceeds of approximately $...
Via
Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
↗
June 28, 2021
Gainers SCWorx (NASDAQ:WORX) shares rose ...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For May 21, 2021
↗
May 21, 2021
Upgrades According to JP Morgan, the prior rating for ResMed Inc (NYSE:RMD) was changed from Neutral to Overweight. For the third quarter, ResMed had an EPS of $1.30,...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
↗
May 19, 2021
Barclays reduced Apple Inc. (NASDAQ: AAPL) price target from $138 to $134. Apple shares fell 1.1% to $123.47 in pre-market trading. UBS lifted Wells Fargo & Company (NYSE:...
Via
Benzinga
The Daily Biotech Pulse: FDA Rejection For Protalix, Amgen Q1 Trail Estimates, Pfizer Goes Shopping
↗
April 28, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 27) Aldeyra Therapeutics, Inc...
Via
Benzinga
Stocks That Hit 52-Week Highs On Tuesday
↗
April 27, 2021
Tuesday's morning session saw 205 companies set new 52-week highs. Interesting Highlights: Wells Fargo (NYSE:WFC) was the largest firm on a market cap basis to set a...
Via
Benzinga
The Daily Biotech Pulse: Lilly, Novartis Trail Q1 Estimates, Exec Departure At Applied Genetics, Patent Award For Scholar Rock, Aldeyra Data Readout
↗
April 27, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 26) 10x Genomics, Inc. (NASDAQ...
Via
Benzinga
Topics
Intellectual Property
10 Biggest Price Target Changes For Tuesday
↗
April 13, 2021
Rosenblatt boosted NVIDIA Corporation (NASDAQ: NVDA) price target from $700 to $800. NVIDIA shares fell 0.2% to $607.00 in pre-market trading. Keybanc boosted the price target...
Via
Benzinga
Zentalis's Early WEE1 Inhibitor Data Shows 'Exceptional' Response In Solid Tumor Study, Plans Combination Trials
↗
April 12, 2021
Zentalis Pharmaceuticals Inc (NASDAQ: ZNTL) has announced initial efficacy and safety data from the Phase 1 dose-escalation portion of its ongoing Phase 1/2...
Via
Benzinga
51 Biggest Movers From Friday
↗
April 12, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares climbed 50.9% to close at $21.60 on Friday after the company announced a worldwide licensing agreement with Pfizer to develop and...
Via
Benzinga
38 Stocks Moving In Friday's Mid-Day Session
↗
April 09, 2021
Gainers Celcuity Inc. (NASDAQ: CELC) shares jumped 64.5% to $23.54 after the company announced a worldwide licensing agreement with Pfizer to develop and commercialize...
Via
Benzinga
< Previous
1
2
3
4
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
Starting at $3.75
/
week.
Subscribe Today